Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Figure 1

Time to treatment failure and overall survival according to p53 status, as assessed by immunochemistry. (a) Time to treatment failure and (b) overall survival. Patients were classified as p53 positive (solid line) or p53 negative (dashed line) as determined by immunochemistry with D07 antibody. A positive case is defined as ≥10% positive, localization of nuclear or nuclear and cytoplasmic, and intensity of stain weak, moderate, or intense. IHC, immunohistochemistry.

Back to article page